Arialys Therapeutics, a clinical-stage biotechnology company pioneering new precision medicines for autoimmune neuropsychiatry, announced the appointment of Sankalp “Sam” Gokhale, M.D., as Chief Medical...
Molecular Partners, a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics, announced the strengthening of a previously...
Agilent Technologies Inc. announced the release of its next generation Agilent InfinityLab LC Series portfolio, which includes the 1290 Infinity III LC, 1260 Infinity...
Seaport Therapeutics, a clinical-stage biopharmaceutical company that is advancing novel neuropsychiatric medicines with a proven strategy and team, announced the closing of an oversubscribed...
Lexicon Pharmaceuticals, Inc. announced that Viatris Inc. has obtained an exclusive license from Lexicon to commercialize sotagliflozin outside of the United States and Europe...
